Outcomes with Intra-gastric Balloon Therapy in BMI < 35 Non-morbid Obesity: 10-Year Follow-Up Study of an RCT.
Daniel L ChanJosil R CruzWilfred L MuiSimon K H WongEnders Kwok Wai NgPublished in: Obesity surgery (2020)
IGB delivers weight loss to 2 years and is superior to control. However, new comorbidity development is not significantly different at 10 years. Patient that received IGB therapy were subsequently more willing for further bariatric metabolic intervention.